Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Change in Accured Expenses (2016 - 2025)

Chemours has reported Change in Accured Expenses over the past 12 years, most recently at -$95.0 million for Q4 2025.

  • Quarterly results put Change in Accured Expenses at -$95.0 million for Q4 2025, down 163.89% from a year ago — trailing twelve months through Dec 2025 was -$3.0 million (up 99.55% YoY), and the annual figure for FY2025 was -$3.0 million, up 99.55%.
  • Change in Accured Expenses for Q4 2025 was -$95.0 million at Chemours, down from $22.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for CC hit a ceiling of $642.0 million in Q4 2023 and a floor of -$644.0 million in Q2 2024.
  • Median Change in Accured Expenses over the past 5 years was $8.5 million (2025), compared with a mean of $1.4 million.
  • Peak annual rise in Change in Accured Expenses hit 301.25% in 2023, while the deepest fall reached 688.89% in 2023.
  • Chemours' Change in Accured Expenses stood at -$337.0 million in 2021, then rose by 5.34% to -$319.0 million in 2022, then surged by 301.25% to $642.0 million in 2023, then crashed by 105.61% to -$36.0 million in 2024, then tumbled by 163.89% to -$95.0 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$95.0 million (Q4 2025), $22.0 million (Q3 2025), and $75.0 million (Q2 2025) per Business Quant data.